According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

PCR, or Polymerase Chain Reaction, is a revolutionary molecular biology technique that allows for the rapid amplification of specific DNA sequences. It is an essential tool in various fields, ...

Chaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya, Palampur, successfully concluded a two-day workshop on ...

Newborn babies admitted to the hospital's neonatal intensive care unit (NICU) rely on the quick decisions and rapid action of the medical team responsible for them. DNA testing is critical to ...

American geneticist who shared a Nobel Prize for discovering the double helix structure of DNA. Born on April 6, 1928 in Chicago, IL, USA, he died aged 97 years in East Northport on Long Island, NY, ...

Explore trends before investing – request a sample report today! A central growth driver for the Norway Aquaculture Vaccines Market is the nation’s strict sustainability standards, which prioritize ...

This volume offers recommendations for handling DNA samples, performing calculations, and other aspects of using DNA as a forensic tool. It addresses two major areas - determination of DNA profiles ...

Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...

Completed strategic pivot from R&D focus to commercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize commercial engagement and investor relationsAdvanced mu ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the ...

The HER2-positive gastric cancer market is set for sustained growth, driven by rising global disease prevalence and expanded HER2 testing that increases the number of patients eligible for targeted ...